12-Dose Isoniazid-Rifapentine Latent Tb Infection Treatment Dose And Symptom Monitoring Log

ADVERTISEMENT

Patient Name: ____________________________ County: _______________________
BASIC INFORMATION LOG: 12-Dose Isoniazid-Rifapentine Latent TB Infection Treatment Dose and Symptom Monitoring
Patient ID: ____________ Age:________ Sex: M / F Ethnicity: Hispanic / Non-Hispanic
Race: ______ Weight: ________lbs Height: ______ft/inches
Treatment reason: ☐Contact
☐Corrections
☐Homeless
☐Refugee
☐Foreign-born
☐Convertor
Dose: INH ______mg RPT______mg
*Check
symptoms or events reported on the listed date; otherwise, leave blank.
Date:
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
0
Dose:
2
3
4
5
6
7
8
9
10
11
12
1
Baseline
Directly Observed Therapy
(DOT) received
No adverse reaction
Loss of appetite
Nausea or vomiting
Yellow eyes or skin
Diarrhea
Rash/hives
Fever or chills
Sore muscles or joints
Numbness or tingling
Fatigue
Dizziness/fainting
Abdominal pain
(Other)______________
Treatment stopped or held
(complete AE report on next page)
Final Disposition: ☐ Completed INH-RPT treatment
☐ Stopped INH-RPT treatment
Date __/__/__
☐ Lost to follow-up
☐ Moved
☐ Other
☐ Adverse event
(fill out next page if treatment stopped for AE)
☐ Pending Completion of Alternate Regimen

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go
Page of 2